Marion McCourt - 03 Jan 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/** Marion McCourt
Issuer symbol
REGN
Transactions as of
03 Jan 2023
Net transactions value
-$384,340
Form type
4
Filing time
05 Jan 2023, 15:22:31 UTC
Previous filing
20 Dec 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $409,706 +1,100 +5% $372.46 23,179 03 Jan 2023 Direct F1
transaction REGN Common Stock Sale $794,046 -1,100 -4.7% $721.86 22,079 03 Jan 2023 Direct F1
holding REGN Common Stock 138 03 Jan 2023 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,100 -11% $0.000000 8,750 03 Jan 2023 Common Stock 1,100 $372.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.